|
US6150328A
(en)
|
1986-07-01 |
2000-11-21 |
Genetics Institute, Inc. |
BMP products
|
|
US6291206B1
(en)
|
1993-09-17 |
2001-09-18 |
Genetics Institute, Inc. |
BMP receptor proteins
|
|
DK0733109T3
(da)
|
1993-12-07 |
2006-07-03 |
Genetics Inst Llc |
BMP-12, BMP-13 og seneinducerende præparater dermed
|
|
WO1999061044A1
(en)
*
|
1998-05-28 |
1999-12-02 |
The Board Of Trustees Of The University Of Arkansas |
Noggin and antagonists of bone morphogenetic proteins to suppress pathologic bone resorption
|
|
US6395511B1
(en)
*
|
1998-11-27 |
2002-05-28 |
Darwin Discovery, Ltd. |
Nucleic acids encoding a novel family of TGF-β binding proteins from humans
|
|
US6727224B1
(en)
|
1999-02-01 |
2004-04-27 |
Genetics Institute, Llc. |
Methods and compositions for healing and repair of articular cartilage
|
|
US7189392B1
(en)
|
1999-10-15 |
2007-03-13 |
Genetics Institute, Llc |
Injectable carrier formulations of hyaluronic acid derivatives for delivery of osteogenic proteins
|
|
CA2449008A1
(en)
|
2001-06-01 |
2002-12-12 |
Wyeth |
Compositions and methods for systemic administration of sequences encoding bone morphogenetic proteins
|
|
EP1801240A1
(en)
*
|
2001-06-05 |
2007-06-27 |
Auckland Uniservices Limited |
Methods and compositions for assessment of pulmonary function and disorders
|
|
WO2002100426A1
(en)
*
|
2001-06-08 |
2002-12-19 |
Smith & Nephew Plc |
Bmp binding proteins for use in bone or cartilage regeneration
|
|
TWI267378B
(en)
|
2001-06-08 |
2006-12-01 |
Wyeth Corp |
Calcium phosphate delivery vehicles for osteoinductive proteins
|
|
GB2385052A
(en)
|
2002-02-05 |
2003-08-13 |
Leuven K U Res & Dev |
Treatment of spondyloarthropathies
|
|
US7193069B2
(en)
|
2002-03-22 |
2007-03-20 |
Research Association For Biotechnology |
Full-length cDNA
|
|
WO2004062621A2
(en)
*
|
2003-01-13 |
2004-07-29 |
Georgia Tech Research Corporation |
Anti-inflammatory agents and methods of their use
|
|
WO2005115439A2
(en)
*
|
2004-05-27 |
2005-12-08 |
Acceleron Pharma Inc. |
Cerberus/coco derivatives and uses thereof
|
|
US9045553B2
(en)
|
2004-05-27 |
2015-06-02 |
Acceleron Pharma, Inc. |
Cerberus/Coco derivatives and uses thereof
|
|
CA2608142A1
(en)
*
|
2005-05-10 |
2006-11-16 |
Synergenz Bioscience Limited |
Methods and compositions for assessment of pulmonary function and disorders
|
|
JP2008545390A
(ja)
*
|
2005-05-19 |
2008-12-18 |
シナージェンズ バイオサイエンス リミティド |
遺伝的多型を用いた肺癌を発達させるリスクの評価方法
|
|
AU2006248200A1
(en)
*
|
2005-05-19 |
2006-11-23 |
Synergenz Bioscience Limited |
Methods and compositions for assessment of pulmonary function and disorders
|
|
AU2006248189A1
(en)
*
|
2005-05-20 |
2006-11-23 |
Synergenz Bioscience Limited |
Methods of analysis of polymorphisms and uses thereof
|
|
WO2007142818A2
(en)
*
|
2006-05-17 |
2007-12-13 |
Stryker Corporation |
Use of a soluble morphogenic protein complex for treating cartilage defects
|
|
WO2008073351A2
(en)
*
|
2006-12-08 |
2008-06-19 |
Acceleron Pharma Inc. |
Uses of cerberus, coco and derivatives thereof
|
|
CN105759056B
(zh)
*
|
2016-04-06 |
2017-11-14 |
四川大学华西医院 |
一种肺癌筛查试剂盒
|
|
JP2020502218A
(ja)
|
2016-12-21 |
2020-01-23 |
メレオ バイオファーマ ３ リミテッド |
骨形成不全症の処置における抗スクレロスチン抗体の使用
|